about
Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis.Current and Future Prospects for Epigenetic Biomarkers of Substance Use DisordersMultigenerational and transgenerational inheritance of drug exposure: The effects of alcohol, opiates, cocaine, marijuana, and nicotineCyclin-Dependent Kinase Inhibitor 1a (p21) Modulates Response to Cocaine and Motivated Behaviors.Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence.Drug-seeking motivation level in male rats determines offspring susceptibility or resistance to cocaine-seeking behaviour.Early-life stress interactions with the epigenome: potential mechanisms driving vulnerability toward psychiatric illness.Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndromeA research agenda for gender and substance use disorders in the emergency department.Quantitative trait locus mapping of acute functional tolerance in the LXS recombinant inbred strains.Genetic and Environmental Interplay in Adolescent Substance Use Disorders.The association of DNA methylation and brain volume in healthy individuals and schizophrenia patientsThe MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency.H4K5 histone acetylation of BRG1 is associated with heroin administration rather than addictionEpigenetics, drugs of abuse, and the retroviral promoter.A network medicine approach to psychiatric genetics.Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land?Therapies in early development for the treatment of opiate addiction.The Genomics of Neonatal Abstinence Syndrome.Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder.Catechol-O-methyltransferase gene methylation and substance use in adolescents: the TRAILS study.Evaluating Exercise as a Therapeutic Intervention for Methamphetamine Addiction-Like Behavior.
P2860
Q22251269-3D47C932-17B7-4BD7-AF3C-D9651FA2AD66Q26782279-E00467EA-1ED7-4D92-9045-D6AFAD90EFBEQ27022465-06A0B96C-2622-45F4-A1C4-69761A316893Q30733424-22471E3A-689E-4DA1-8E03-BAA9C6E368D9Q31008696-BF40D9DA-2BF9-47A5-A93B-6DF79AA5F5BAQ33766608-5B5C60EF-A236-40AC-A809-57D1798E6B43Q33992088-33FF8F0C-569E-40C8-96FA-B69A7F32E401Q34090556-9AA50D37-8A18-45CA-A606-F21E52DD14B2Q35054784-BA988709-7C4E-49C5-B6EB-8BC5253C0768Q35256240-595FA645-3452-4169-A800-1E856F0CC67EQ35967020-6B6E2279-69E3-4DF6-9A5E-160E49F759B9Q36378014-C8FB9924-1DB2-401B-A588-38BF2DD62A35Q36529100-266D06D5-9EE0-4F40-8770-10F59B4EA8F2Q37204376-30EF3D79-7FCF-4E14-A93B-5636C684DB86Q37425468-3BEE2531-FEA5-498A-B63E-AF83B4C2C7DEQ38153339-0EAF46D6-F943-4E52-9ECA-4F22BD3C7C4AQ38479762-7B54374C-01FE-4006-B357-AB72D3ED1EA3Q38594606-B9B76FCB-A245-4723-BAC5-0D977CCC4967Q41525356-B9FD0F4F-5734-4988-A312-01BCF4CC728DQ44342878-A71D6449-9937-4AB8-943B-B55D08A6C4B6Q48734129-A16134F0-AD4B-4115-98C6-6AB89676431AQ55286284-470C695A-2043-438A-9FDE-BE2F2CF82428
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Epigenetics of drug abuse: predisposition or response.
@ast
Epigenetics of drug abuse: predisposition or response.
@en
type
label
Epigenetics of drug abuse: predisposition or response.
@ast
Epigenetics of drug abuse: predisposition or response.
@en
prefLabel
Epigenetics of drug abuse: predisposition or response.
@ast
Epigenetics of drug abuse: predisposition or response.
@en
P2093
P2860
P356
P1433
P1476
Epigenetics of drug abuse: predisposition or response.
@en
P2093
Amol Utrankar
Daniel D Simons
David A Nielsen
Jennifer A Reyes
Thomas R Kosten
P2860
P304
P356
10.2217/PGS.12.94
P577
2012-07-01T00:00:00Z